about
The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factorsExome sequencing identifies MAX mutations as a cause of hereditary pheochromocytomaGenome-wide association study identifies ephrin type A receptors implicated in paclitaxel induced peripheral sensory neuropathyMultilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors.Hematologic β-tubulin VI isoform exhibits genetic variability that influences paclitaxel toxicity.Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomasGenetic anticipation is associated with telomere shortening in hereditary breast cancer.Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.An epistatic interaction between the PAX8 and STK17B genes in papillary thyroid cancer susceptibility.Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to exploreImpact of chemotherapy on telomere length in sporadic and familial breast cancer patients.Regulatory polymorphisms in β-tubulin IIa are associated with paclitaxel-induced peripheral neuropathy.Deep sequencing reveals microRNAs predictive of antiangiogenic drug responseMolecular insights into the OGG1 gene, a cancer risk modifier in BRCA1 and BRCA2 mutations carriersGenetic variation in the SLC19A1 gene and methotrexate toxicity in rheumatoid arthritis patients.SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.Functional and in silico assessment of MAX variants of unknown significance.DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers.MicroRNA deep-sequencing reveals master regulators of follicular and papillary thyroid tumors.Targeted Sequencing Reveals Low-Frequency Variants in EPHA Genes as Markers of Paclitaxel-Induced Peripheral Neuropathy.Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients.Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade.Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases.Allelic variant at -79 (C>T) in CDKN1B (p27Kip1) confers an increased risk of thyroid cancer and alters mRNA levels.Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma.DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.Overexpression and activation of EGFR and VEGFR2 in medullary thyroid carcinomas is related to metastasis.MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaThyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populationsHigh frequency and founder effect of the CYP3A4*20 loss-of-function allele in the Spanish population classifies CYP3A4 as a polymorphic enzymeCorrection: An Epistatic Interaction between the PAX8 and STK17B Genes in Papillary Thyroid Cancer SusceptibilityIntegrative analysis of miRNA and mRNA expression profiles in pheochromocytoma and paraganglioma identifies genotype-specific markers and potentially regulated pathwaysTumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisThe miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patientsDNA copy number profiling reveals different patterns of chromosomal instability within colorectal cancer according to the age of onset
P50
Q21092455-2D09B5FC-0357-4D70-B329-852B1D6B5D23Q28241168-E325CBAE-BE95-4787-999F-AAEE7E07D23CQ28943314-3A955830-909F-4FAE-8EAE-91595396F3ECQ31129981-8C251064-0720-4040-80B6-A4468A81D1EDQ33402393-A195B6E7-E3F8-4FD4-91AC-99EF9E2BE2DDQ33637176-CA4446E7-048A-4445-83B4-D50C2E9F4A9AQ33987513-17C960C1-363B-4B5C-990A-88C57DBBFC1AQ34466932-DBCE9541-1197-4D21-A08D-B4C2D319447BQ35005124-38D26540-F7CD-4F6A-8869-AF0173927BDDQ35993186-7421B870-B2C7-492E-8D91-733A0C1C7BCFQ36776304-70193C00-924B-4FE9-98AF-1CEB0A4F9C85Q36877796-DEDF5CE3-66B0-4AC9-BCBA-42AC39C742B4Q37277227-72E8BB5E-5801-4360-87AA-171F44984CA9Q37295507-2F73766F-DDA6-4BB7-8A91-A058FD648FB9Q39245507-3786DD8B-85A5-40DD-A79C-80EFFF30BA49Q39276801-AB58B1E3-7251-4001-A825-E883CBE04207Q40840010-F6186EE8-BCF5-4B85-96C4-787B2C253DBAQ41137119-64CB1CE8-AD8E-4628-B4B7-7491252A77E3Q41346876-91A2FB7E-98CC-4F8C-B01C-F0A54620619DQ50220717-A4909A88-328A-4B2A-9FE5-95D0F4C7E397Q50438414-1EAB563C-38D2-4AB2-BA6D-7EAAF4D5AA92Q50485878-F8C15B79-C9D5-4AFD-9879-0AFE3E46F0E6Q51347290-20C9F321-368C-4878-A3CB-6736BF5F006DQ53348388-164C33B1-6ACE-45C3-9DC3-A96E4ED41B51Q53474457-6733F322-14FB-4B90-A8FC-CF5B3CED7125Q54358248-CC7CDCC6-A538-414C-BC9D-1B60E42F6FEAQ54387117-9E865644-160C-43DD-901F-764A5848DEDEQ54719085-99E378E4-AA29-4959-8B02-546E77870CF4Q56964302-618C50BD-8EF9-49F0-AB08-459B51203A95Q57083774-215237D8-BA1D-49C5-88E3-2D4EB5CF7515Q57083779-CA2448AC-6DF4-4CE5-807D-1BD1A6F8FD5DQ60559900-4A15F5D6-4015-4459-9B8D-0A0111894230Q60895632-DD2CC5D4-50D8-440A-9766-D0331E28AFBFQ60895635-3E7B0A2F-07B3-4DF3-9CEC-3BB6BD384C30Q60895640-4A19DB1E-6CC7-4BE3-A84B-10DFED9076A5Q64049502-9BFAB800-37C4-4CE3-8A2B-798BA67A5BFA
P50
description
researcher ORCID ID = 0000-0001-9814-4368
@en
wetenschapper
@nl
name
L Inglada-Pérez
@ast
L Inglada-Pérez
@en
L Inglada-Pérez
@es
L Inglada-Pérez
@nl
type
label
L Inglada-Pérez
@ast
L Inglada-Pérez
@en
L Inglada-Pérez
@es
L Inglada-Pérez
@nl
altLabel
Lucia Inglada-Pérez
@en
prefLabel
L Inglada-Pérez
@ast
L Inglada-Pérez
@en
L Inglada-Pérez
@es
L Inglada-Pérez
@nl
P106
P1153
35078660900
P31
P496
0000-0001-9814-4368